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ORIGINAL ARTICLE
The Rift Valley fever accessory proteins NSm and P78/
NSm-GN are distinct determinants of virus propagation in
vertebrate and invertebrate hosts
Felix Kreher1,2,3, Carole Tamietti1,2, Ce´line Gommet4,5,6,*, Laurent Guillemot4,5,*, Myriam Ermonval1,*,
Anna-Bella Failloux7, Jean-Jacques Panthier4,5, Miche`le Bouloy1 and Marie Flamand1,2
Rift Valley fever virus (RVFV) is an enzootic virus circulating in Africa that is transmitted to its vertebrate host by a mosquito vector and
causes severe clinical manifestations in humans and ruminants. RVFV has a tripartite genome of negative or ambisense polarity. TheM
segment contains five in-frame AUG codons that are alternatively used for the synthesis of two major structural glycoproteins, GN and
GC, and at least two accessory proteins, NSm, a 14-kDa cytosolic protein, and P78/NSm-GN, a 78-kDa glycoprotein. To determine the
relative contribution of P78 and NSm to RVFV infectivity, AUG codons were knocked out to generate mutant viruses expressing various
sets of the M-encoded proteins. We found that, in the absence of the second AUG codon used to express NSm, a 13-kDa protein
corresponding to an N-terminally truncated form of NSm, namedNSm9, was synthesized from AUG3. None of the individual accessory
proteins had any significant impact on RVFV virulence in mice. However, a mutant virus lacking both NSm and NSm9 was strongly
attenuated in mice and grew to reduced titers in murine macrophages, a major target cell type of RVFV. In contrast, P78 was not
associated with reduced viral virulence inmice, yet it appeared as amajor determinant of virus dissemination inmosquitoes. This study
demonstrates how related accessory proteins differentially contribute to RVFV propagation in mammalian and arthropod hosts.
Emerging Microbes and Infections (2014) 3, e71; doi:10.1038/emi.2014.71; published online 1 October 2014
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INTRODUCTION
Rift Valley fever virus (RVFV), which is enzootic in Africa, was first
isolated in 1930 during a major outbreak in Kenya.1,2 RVF manifesta-
tions were initially recognized through numerous abortions in preg-
nant ewes and a high mortality rate in young animals.1 Over the past
decades, recurrent outbreaks of this virus have occurred mostly in
sub-Saharan countries, such as Madagascar and Egypt.3–5 The recent
introduction of the virus into the Arabian Peninsula has raised con-
cerns for a possible spread of the virus throughout southern Europe.6,7
RVFV can be transmitted to its hosts during feeding of a mosquito
vector or by direct contact with contaminated fluids.8–10 The disease in
humans is most commonly a self-limited, flu-like syndrome, butman-
ifestations such as hepatitis, jaundice, retinitis, meningo-encephalitis
or signs of hemorrhages are frequently observed in the severe forms of
RVF.3,9,11–13 The overall fatality rate in humans usually remains below
1%, although this rate has exceeded 10% in recent epidemics.3,10
RVFV belongs to the family Bunyaviridae, which is divided into
five genera (Orthobunyavirus, Nairovirus, Phlebovirus, Hantavirus and
Tospovirus). The family comprises major human pathogens such as
hantavirus (Hantavirus), Crimean-Congo hemorrhagic fever virus
(Nairovirus), RVFV and severe fever with thrombocytopenia syn-
drome virus (Phlebovirus).14 RVFV is an enveloped virus containing
a tripartite RNA genome of negative or ambisense polarity.15,16 The L
segment codes for the RNA-dependent RNA polymerase, and the S
segment utilizes an ambisense strategy to express the nucleoprotein
N and non-structural protein NSs, which is a major virulence factor.
The M segment is composed of one large open reading frame that
encodes the two envelope glycoproteins GN and GC and contains an
additional upstream NSm region, the translation of which depends on
the alternative usage of five in-frame AUG codons (Figure 1A).15
Translational products of the M segment have been characterized in
vitro and consist of a nested set of polyproteins that are expressed from
different AUG codons, presumably through a leaky scanning mech-
anism. The polyprotein precursors are then cleaved by cellular signalases
to generate the individual proteins.17–19 Initiation of translation at the
first AUG codon leads to synthesis of a NSm–GN–GC precursor that
contains a signal sequence upstream of NSm, which allows for trans-
location of the polyprotein into the endoplasmic reticulum (Figure 1B).11
In this context, cleavage only occurs after the NSm and GC signal pep-
tides, leading to the release of a 78-kDa glycoprotein, namely, P78,
NSm1 or the large glycoprotein, which consists of an NSm–GN fusion
protein.11 GC is cleaved from the precursor, but may be highly unstable
in the absence of a functional GN. Initiation of translation from AUG 2
takes place downstream of the signal sequence of NSm such that the
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NSm amino-acid sequence remains on the cytosolic side of the mem-
brane and only the two structural glycoproteins, GN and GC, enter the
lumen of the endoplasmic reticulum (Figure 1B).15 Cleavage of this
NSm–GN–GC precursor occurs after the signal sequences of GN and
GC, giving rise to NSm, a 14-kDa protein that was initially referred to
as NSm2, in addition to the GN and GC proteins (Figure 1B).
15 AUG 4
and AUG 5, which are localized downstream of the NSm region, also
contribute to GN and GC expression, while AUG 3 does not seem to
play a significant role in translation initiation.19
The P78 glycoprotein localizes to the Golgi complex.20 It has been
found to form heterodimers with the GC envelope protein and to co-
sediment with virus or virus-like particles.21–24 A recent report shows
an association of this proteinwith virus particles produced fromC6/36
mosquito cells but not from simian Vero E6 cells infected with RVFV,
suggesting an important role of P78 in the insect vector.25 Although
the cytosolic non-structural NSm protein shares the same amino-acid
sequencewith theN-terminal portion of P78, it has a very different fate
from its glycoprotein counterpart. NSm is specifically targeted to the
outer membrane of mitochondria, where it may impede activation of
the apoptotic cascade and regulate the p38 mitogen-activated protein
kinase response.26 Neither P78 nor NSm are required during viral
replication in mammalian (Vero or MRC5) or mosquito (C6/36) cell
cultures.27,28 However, a recombinant RVFV deleted of the full NSm
region, which accordingly lacks expression of the two accessory
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Figure 1 Description of the different proteins encoded by the RVFVM segment. (A) Schematic representation of the RVFVM segment in the antigenomic orientation.
The relative nucleotide position of the different in-frame AUG codons in the NSm region and the coding regions of NSm, GN and GC are depicted on the upper graph.
Transmembrane domains are indicated as gray rectangles. This panel also shows the schematic representation of the polypeptides expressed from each of the AUG
codons. Different proteins, including P78 and NSm (red), GN (blue) and GC (green), are generated upon cleavage of polyprotein precursors. (B) Model of protein
topology in the context of different AUG usage. (C) Description of the AUG KOmutant viruses produced during this study, with their corresponding protein expression
profiles. ER, endoplasmic reticulum.
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proteins, is highly attenuated in rats and shows a reduced ability to
infect mosquitoes.29–31
A detailed functional analysis using mice and mosquitoes as experi-
mental models is now needed to specify the role of the different M-
encoded accessory proteins during virus infection of vertebrate and
invertebrate hosts. To this end, we generated a set of mutant viruses in
which one or several AUGs in the M segment were knocked out (KO)
(Figure 1C). We found that NSm is an important determinant of
RVFV virulence in mice, while P78 plays no apparent role in this
animal model. In contrast, mutant viruses that lack expression of
P78 show poor to no dissemination in the mosquito vector. In agree-
ment with these observations, we observed that the respective AUG
KO mutant viruses replicate to substantially lower levels in murine
macrophages and mosquito cells cultured in vitro.
MATERIALS AND METHODS
Cell lines
Baby hamster kidney cells stably expressing T7 polymerase (BHK/T7-
9)32 (kindly provided by Naoto Ito Gifu, Japan) were cultured in min-
imum essential medium supplemented with 10% fetal calf serum (FCS;
Biowest, Nuaille´, France) and Tryptose phosphate broth. Vero E6 cells
(kindly provided by Stephen Goodbourn, London, UK) were grown
in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco, Life
Technologies, Cergy-Pontoise, France) supplemented with 10% FCS.
Murine fibroblastic L929 cells and murine macrophage RAW 264.7 cells
(ATCC, LGC Standards, Molsheim, France) were cultured in DMEM
supplemented with L-glutamine and 10% FCS. Mammalian cells lines
were maintained at 37 6C under 5%CO2 in medium supplemented with
10 IU of penicillin and 10 mg of streptomycin per mL. Aedes albopictus-
derived C6/36 cells were grown in Leibowitz’s L-15medium (Gibco, Life
Technologies, Cergy-Pontoise, France) supplemented with 10% FCS
(Lonza, Verviers, Belgium) and 2% Tryptose phosphate broth
(Sigma-Aldrich, Lyon, France) and incubated at 28 6C without CO2.
Plasmids
Plasmids containing the L, M or S segments of RVFV (ZH548 strain)
located downstream of the Pol-l promoter in pRF108 have been
described.33 pRF108-M, which encodes the M segment, was used to
generate single AUG-to-GCG mutations or combinations of KO
mutations by site-directed mutagenesis. The mutants were sequenced
for the presence of the targeted mutations as well as the absence of
additionalmutations. The viral proteinsN and Lwere expressed under
the control of the T7 promoter/terminator and encephalomyocarditis
virus internal ribosomal entry site using the pTM1 plasmid.
Virus production
RVFV was rescued by transfecting BHK/T7-9 cells as previously
described.33 Briefly, cells were transfected using Fugene6 reagent
(Roche Diagnostics, Meylan, France) according to the manufacturer’s
instructions using a ratio of Fugene6 to plasmid DNA of 3 mL/mg of
pTM1-N, pTM1-L and pRF108-L, -M and -S. Medium was collected
3–5 days post-transfection, stored at 280 6C and used to produce virus
stocks. The NSm region of the M segment was then entirely sequenced.
Subconfluent monolayers of Vero E6 cells were infected with RVFV
ZH548 or recombinant viruses at a multiplicity of infection (MOI) of
0.01 inDMEMsupplementedwith 2%FCS and antibiotics. Themedium
was collectedwhenacytopathic effectwasobservedat approximately 72 h
post-infection (PI). Supernatants were clarified and stored at 280 6C.
Virus was titrated via plaque assay on Vero E6 cells incubated under a
1% agarose layer for 3–4 days at 37 6C, and plaques were stained with a
crystal violet solution at 0.2% in 10% formaldehyde and 20% ethanol.
Virus stability
Viruses were passaged on confluent Vero E6 cells infected at a MOI of
0.01 to follow the emergence of compensatory mutations over five
sequential rounds of infections. RNA was extracted from infected cells
at each passage using TRIzol reagent (Invitrogen, Life Technologies)
according to the manufacturer’s instructions. 39-rapid amplification of
cDNA ends (39 RACE) was then carried out using a poly(A) polymerase
tailing kit (Epicentre Biotechnologies, Tebu-Bio, Le Perray en Yvelines,
France). Briefly five micrograms of total RNA was polyadenylated in a
20-mL reaction mixture for 7 min at 37 6C. The RNA was then purified,
and reverse transcription was carried out using the oligo(dT) 39 RACE-
adaptor primer (AP) (Invitrogen) or primers specific for theM segment
and avian myeloblastosis virus reverse transcriptase (RT) (Promega,
Charbonnie`res, France). This step was followed by polymerase chain
reaction (PCR) using the KOD polymerase (Toyobo, Merk, Darmstadt,
Germany) and specific primers and/or 39 RACE-AP. The resulting RT-
PCR products were separated by agarose electrophoresis, and the DNA
bands with the correct sizes were purified using the QIAquick purifica-
tion kit (Qiagen, Courtaboeuf, France) and then sequenced according
to standard protocols using the BigDye terminator v1.1 kit (Applied
Biosystems, Villebon-sur-Yvette, France).
Western blotting
Infected cells were washed with phosphate buffered saline (PBS) and
lysed using NET buffer containing 1% (v/v) Triton X-100, 0.5% sodium
dodecyl sulfate (SDS) and protease inhibitors (Complete Protease
Inhibitor; Roche) and incubated 5 min on ice. The cell lysates were
centrifuged at 10 000g for 10 min, and a jelly-like pellet containing
mostly DNA was removed. The protein content was quantified using a
micro-BCA test (Thermo Fischer Scientific, Illkirch, france), and equal
amounts of total proteins were loaded onto 10% or 12% SDS–polyacry-
lamide gels (BioRad, Marnes-la-Coquette, France) in reducing condi-
tions. The proteins were then transferred onto nitrocellulose membranes
(Amersham, GE Healthcare Europe GmbH, Velizy-Villacoublay,
France). The membranes were blocked with a solution of 5% dried skim
milk in PBS containing 0.05% Tween 20, which was also used to dilute
the antibodies (Abs). The 4D4mouse monoclonal antibody (Ab) (kindly
provided by Dr C Schmaljohn) was used to detect GN. TheN protein was
detected using a rabbit polyclonal Ab raised against a recombinant pro-
tein produced in the baculovirus system, and NSm-related proteins
were detected using a rabbit polyclonal Ab directed against a peptide
corresponding to the 13 amino acids downstream of AUG 2 (MC14)
(MIEGAWDSLREEE). V5-tagged proteins were detected using an anti-
V5 Ab (Invitrogen). Immunodetection was performed by incubating the
membranes with an anti-mouse or anti-rabbit Ab coupled to horseradish
peroxidase (Sigma-Aldrich) followed by incubation with a chemilumin-
escent substrate (ECL Pierce/Thermo Fischer Scientific). Signals were
detected by film exposure (Amersham) or using a G-box (Ozyme,
Montigny-Le-Bretonneux, France).
Immunofluorescence microscopy
Cells grown for 24 h on coverslips were infected with wild type (WT) or
mutant viruses. The infected cells were then fixed at the indicated time
PI with 3.7% formaldehyde in PBS for 30 min at room temperature,
permeabilized with 0.05% TritonX-100 for 10 min and then saturated
with PBS containing 3% FCS and 0.05% Tween 20 for 30 min. The Abs
were diluted in PBS containing 3% FCS and 0.05% Tween 20 and
incubated 1 h at room temperature. The same Abs as those used for
Western blotting were used for the detection of GN, N protein, NSm-
related proteins and V5; and TOM22was detected using an anti-TOM22
F Kreher et al
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mouse monoclonal Ab (Sigma-Aldrich, Lyon, France). Alexa Fluor 555-
and Alexa Fluor 488-conjugated goat anti-mouse or anti-rabbit Abs were
used as secondary Abs (Molecular Probes, Life Technologies). Image
acquisition was performed with a Zeiss Axiovert 200M inverted micro-
scope (Imagopole; Institut Pasteur, Paris, France). A series of grid-pro-
jection acquisitions allowed for optical slice view reconstruction using
the Zeiss Axiovision 4.8 software.
Mouse virulence assays
Inbred female C57BL/6J mice were purchased from Charles River
Laboratories (L’Arbresle, France). Groups of 8-week-old mice were
inoculated intraperitoneally with 100 plaque-forming units (PFU) of
RVFV and kept in biosafety level 3 isolators, as previously described.34
The morbidity, mortality and clinical disease scores of the mice were
monitored daily for 14 days following infection. Mice that showed
signs of illness, i.e., ruffled fur and hunched posture, were euthanized.
Animals that survived were euthanized on the last day of the monitor-
ing period.
Mosquito infections
Seven-day-old F1 female Aedes aegypti mosquitoes were infected with
concentrated preparations of virus. To this end, confluent layers of
Vero E6 cells were infected at an MOI of 0.1. At 72 h PI, cell culture
supernatants were collected, and cellular debris was eliminated by cent-
rifugation at 1500g for 10 min at 4 6C. Supernatants were incubated for
4 h with 7.5% (w/v) PEG 6000, and virus particles were pelleted at
10 000g for 45 min at 4 6C. The virus pellets were resuspended in a 20%
sucrose solution in PBS (w/v), and the viruses were then loaded onto a
20 to 60% sucrose gradient and centrifuged at 190 000g for 12 h at 4 6C.
Virus was dialyzed against PBS for 8 h at 4 6C, and titers were deter-
mined using plaque assays. The Hemotek feeding system was used to
provide an infectious blood meal, which was composed of a virus
suspension supplemented with washed rabbit erythrocytes and aden-
osine triphosphate (ATP) (5 mM) at a titer of 6.63107 PFU/mL, at
37 6C to the mosquitoes. Fully engorged females were transferred in
cardboard containers and maintained with 10% sucrose at 2861 6C for
14–21 days. Virus infection and dissemination rates in mosquito heads
and bodies, respectively, which were homogenized in a bead beater in
300 mL of DMEM were evaluated by plaque assays.
Ethics statement
Experiments on livemice were conducted according to the French and
European regulations on care and protection of laboratory animals
(EC Directive 86/609, French Law 2001-486 issued on 6 June 2001)
and the National Institutes of Health Animal Welfare (Insurance
#A5476-01 issued on 2 July 2007). Experimental protocols were
approved by the Animal Ethics Committee #1 of the Comite´
Re´gional d’Ethique pour l’Expe´rimentation Animale, Ile de France
(NO 2012-0025) and carried out in compliance with the Institut
Pasteur Biosafety Committee.
RESULTS
Production and characterization of AUG KO mutant RVFV
To evaluate the relative impact of the NSm-related proteins on viral
virulence, we used site-directed mutagenesis to generate a set of single,
double and triple AUG KO mutations in the RVFV M segment and
used a reverse genetics system to rescue the infectious WT ZH548
strain and its derived mutants (Figure 1C).33 Viruses carrying the
WT or AUG mutants of the M segment were rescued in BHK/T7-9
cells, and viral stocks were produced on Vero E6 cells. All viruses were
analyzed for GN and N expression in infected Vero E6 cells (data not
shown) by immunofluorescence (IF). Consistent with previous
reports, no significant differences could be observed between mutant
and WT virus-infected cells.27,28 Cell lysates from infected Vero E6
cells were further analyzed by Western blotting (Figure 2A), which
showed that all viruses expressed the viral proteins GN andN to similar
levels. We also used anti-NSm Abs generated against a peptide corres-
ponding to the 14 amino acids downstream of AUG 2 (MC14) to
ascertain the presence or absence of the P78 and NSm proteins in cells
infected by the different mutant viruses. As previously reported, we
found that the expression of P78 and NSm depended on the first and
second AUG codons, respectively. Surprisingly, using sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE), we found that
NSm migrated at a higher apparent molecular weight in all mutants
that carried AUG 2 but were mutated at AUG 3 (AUG 3 KO and AUG
113 KO). The type of post-translational processing that accounts for
this difference in migration is unclear.
Expression of an NSm9 protein from the AUG 3 start site
The anti-NSm antibody was not initially designed to detect the N-
terminally truncated form of the NSm protein that may be expressed
from AUG 3 (the MC14 epitope lies upstream of AUG 3). To dem-
onstrate that an NSm9 protein can be synthesized from AUG 3, a V5
tag was introduced downstream of AUG3 in the backbone of an AUG
112 KOmutant virus (Figure 2B). This virus expressed viral proteins
GN and N, as shown by IF analysis of infected cells. Lysates from the
cells infected with the AUG 112 KO/NSm9-V5 mutant virus were
analyzed by Western blotting with a V5-specific Ab. Two bands spe-
cific to V5-tagged proteins were detected: the most prominent one at
approximately 14 kDa represented NSm9 fused to the V5 tag, and a
minor band at approximately 75 kDa corresponded to the NSm9-V5-
GN precursor (Figure 2B). The uncleaved NSm’-GN precursor pro-
duced from AUG 3 had been previously described,26 but the present
results show that a cleaved, N-terminally truncated version of the 13-
kDa NSm9 protein is preferentially produced in RVFV-infected cells.
Association of NSm and NSm9 with mitochondria
It was recently reported that NSm is a C-terminally anchored protein
that is situated on the outer surface of mitochondria.35 Using the
MC14 Ab, we found that NSm expressed in Vero E6 cells infected with
the AUG 1 KO virus colocalized exclusively with the mitochondrial
marker TOM22 (Figure 3A). This analysis also showed that, in cells
infected with an AUG 113 KOmutant virus, which leads to an altered
migration profile of NSm in polyacrylamide gels, mitochondrial tar-
geting of the viral protein was not compromised. Moreover, the sub-
cellular localization of NSm’ fused to a V5-tag was analyzed by IF, and
just like the full-length NSm protein, the V5-tagged protein appeared
to colocalize with the mitochondrial marker TOM22 (Figure 3B),
which indicates that the region between AUG 2 and AUG 3 is not
essential for the subcellular localization of NSm.
Stability of the mutant viruses in mammalian cell culture
Before testing the different mutant viruses in an in vivo model, we
assessed their stability in cell culture (Supplementary Figure S1). To
this end, Vero E6 cells were infected at an MOI of 0.01, and super-
natants were used to infect new cell monolayers. These infection cycles
were repeated several times. RNA was recovered from cells infected by
mutant viruses submitted to five rounds of amplification (passage 5),
and the entire NSm coding region was sequenced. No reversion
of any of the introduced mutations was found. To sequence the
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39-untranslated region of the genomic M segment, i.e., upstream of
AUG 1 at position 21, 39 RACE followed by RT-PCR was carried out.
Interestingly, we found that a new AUG codon upstream of the
mutated AUG 1 was generated through a change of cytosine to uracil
at position 10 in the non-coding region (C10U) of the AUG 1 KO,
AUG 112 KO and AUG 113 KOmutant viruses that were sequenced
at passage 5 (Supplementary Figure S1A). Analysis of the RNA from
the AUG 1 KO mutant at earlier passages revealed a rapid accumula-
tion of the C10U mutation between passages 4 and 5 (Supplementary
Figure S1A). In contrast, this AUG codon was not present in the WT
nor in the AUG 11213 KO viral RNAs that were recovered at passage
5. This new in-frame AUG codon was positioned only two codons
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upstream of a stop codon. However, Western blotting analysis of Vero
E6 cells infected with AUG 1KO virus from either the original stock or
passage 5 showed that P78 could be expressed, albeit to a lower extent,
from the newly introduced initiation site (Supplementary Figure S1B),
suggesting that the in-frame stop codon is too close to the initiation
codon to be recognized. To stabilize the KO of AUG 1 in subsequent
studies, a mutant virus was produced in which two additional stop
codons were introduced at positions 94 and 115, downstream of the
predicted P78 signal sequence. These mutations were designed to
block any translation initated from an AUG codon introduced
upstream of AUG 1 that would restore P78 protein expression. This
AUG S1 KO virus was passaged up to eight times, as previously
described, and analyzed for the introduction of the C10U mutation.
No mutation in the 39-untranslated region could be detected for the
AUG S1 KO virus (data not shown).
Impact of the NSm-related proteins on viral virulence in mice
Various strains of mice have been found to be highly susceptible to
infections by RVFV and to display a similar pattern of symptoms as in
the severe forms of the disease in humans.13,34,36 To analyze the impact
of the different NSm-related proteins on viral virulence, we conducted
an initial animal test in 8-week-old female C57BL/6mice usingmutant
viruses in which single AUG codons were knocked out. Mice were
injected intraperitoneally with 100 PFU of in vitro-reconstituted WT
virus (ZH548) or the different mutant viruses, and the mice were
monitored for 3 weeks (Figures 1C and 4A). No significant changes
in the mice infected with the mutant viruses compared to those
infected with the rescued WT virus, neither in time of death nor in
survival rates, could be observed. This finding was unexpected because
a previous report showed strong attenuation of a RVFV lacking the
NSm region in rats.29 To investigate whether attenuation in mice
AUG 1 KO
AUG 1+3 KO
AUG 1+2+3 KO
AUG 1+2 KO/
NSm’-V5
Merge
WT
V5TOM22
MergeMC14TOM22A
B
Figure 3 Subcellular localization of the NSm and NSm9 accessory proteins. (A) Vero E6 cells infected with either WT ZH548 virus or different AUG KOmutant viruses
were fixed 16 h PI and stained with specific antibodies for the mitochondrial marker TOM22 and the anti-NSmMC14 Ab. Colocalization of the two signals is indicated
by a yellow label in themerged images. (B) Vero E6 cells were either infected with the AUG 112 KONSm9-V5 virus at anMOI of 3. Cells were fixed 16 h PI and stained
with specific Abs for TOM22 (green) and V5 (red). Scale bars represent 20 mm.
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requires the concomitant absence of the NSm and P78 proteins, we
carried out another animal test under the above-described conditions
using a subset of double AUGKOmutant viruses (Figures 1C and 4B).
We tested an AUG 112 KO mutant lacking both the NSm and P78
proteins as well as mutants AUG 113 KO and AUG 213 KO to check
for a possible compensatory role of an AUG 3-derived expression
product. An AUG 415 KO mutant virus encoding all five proteins
GN, GC, P78, NSm and NSm’, as in the WT virus, but retaining only
three of the five AUGs, served as a control. Infectionwith neither of the
twomutants that abrogated the combined expression of P78 andNSm
or NSm9 (AUG 112 KO and AUG 113 KO) led to an attenuated
phenotype. In contrast, the virulence of the AUG 213 KO mutant
virus was substantially reduced in this experiment, with a survival rate
of 66% compared to 0% for theWT virus. These results demonstrated
that NSm is a major determinant of RVFV virulence in mice and that
NSm9 may function as its substitute.
P78 alone did not seem to have any major impact on the outcome
of RVFV infection in mice. To assess a possible introduction of an
AUG that would restore P78 expression in vivo, another animal test
was carried out in which C57BL/6 mice were infected with either
rescued WT virus, the original AUG 1 KO virus or the secured
AUG S1 KO virus (Figure 4C). The AUG S1 KO virus was associated
with a survival rate of 37.5%, which was not significantly different
from the 25% survival rate of mice infected with the original AUG 1
KO virus. In addition, blood samples were recovered from the mice
infected with theWT and AUG 1 KO viruses (two animals per group),
the viruses were amplified in Vero cells, and viral sequences were
analyzed by 39 RACE. No mutation that could restore P78 expression
could be detected in any of the animals tested. Residual virulence of
the AUG 11213 KO virus was further compared to that of the AUG
213 KOmutant virus to assess whether P78 cooperates with the NSm/
NSm9 proteins, which should result in increased attenuation of the
triple KO virus. Infections by the AUG 11213 KO virus led to 75%
survival in infected mice, and infections by the AUG 213 KO virus led
to 80% survival. These results indicated no significant contribution of
the P78 KO to the attenuated phenotype of the AUG 11213 KO
mutant virus.
Next, we attempted to estimate the lethal viral dose leading to 50%
mortality in mice (LD50) for the AUG 213 KO and WT viruses. We
infected mice with 1, 10 and 100 PFU of theWT RVFV or 100, 1000 or
10 000 PFUof the AUG213KOper animal (Figure 4D). In thismouse
model, the LD50 forWTRVFVwas between 1 and 10 PFU. By contrast,
no clear correlation between increased inoculum and mortality rates
could be observed for the AUG 213 KO mutant virus. Furthermore,
mortality remained above 50% and fluctuated from approximately
60% to 70%, even when we increased the inoculum over a thousand
times with respect to the LD50 of the WT virus. These results con-
firmed that the KOs of NSm and NSm9, which were associated with a
change of only two codons, leads to strong attenuation of RVFV in
mice.
Murine macrophages but not fibroblasts discriminate the different
AUG KO mutant viruses in vitro
Two studies that investigated the potential role of the NSm-related
proteins in viral growth in infected cell cultures showed no differences
whether the proteins were present or not.27,28 To assess the behavior of
the mutant viruses produced in the context of the ZH548 strain, we
infectedmurine L929 fibroblasts with themutants or theWT virus at a
MOI of 0.01 or 3 (Figure 5A). As previously reported, no significant
differences could be observed for any of the viruses tested. Because a
recent study demonstrated the importance of macrophages in RVFV
infection in mice,37 we further investigated the growth behavior of
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Figure 4 Residual virulence of the AUGKOmutant viruses in C57BL/6mice. (A,B) Six 8-week-old C57BL/6mice weremock-infected (NI) or infected with 100 PFU of
rescuedWT virus (ZH548) or with 100PFUof the different AUGKOmutant viruses knocked out for one of the first three in-frameAUGstart codons present at the 59 end
of RVFVMsegment (A) or for two of the five start codons (B). Miceweremonitored over a period of 3weeks, but no changes in survival rates were observed after day 14.
(C) Eight-week-old C57BL/6 mice were infected with 100 PFU of rescued WT virus (ZH548) or with 100 PFU of the AUG 1 KO, AUG S1 KO, AUG 213 KO or
AUG 11213 KO mutant viruses. (D) Survival curve of C57BL/6 mice infected with different doses of rescued WT ZH548 virus or AUG 213 KO virus. Eight-week-old
C57BL/6 mice were infected with 1, 10 or 100 PFU of rescued WT ZH548 virus or 100, 1000 or 10 000 PFU of the AUG 213 KO mutant virus.
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mutant RVFV at a low MOI of 0.01 in the murine macrophage-like
RAW 264.7 cell line (Figure 5B). In this cell type, we observed a 2-log
reduction in virus titers for the two mutants that were defective for
NSm and NSm’ expression, which correlated with the attenuated
phenotype inmice. To investigate if this reduction in virus production
resulted from a cell-to-cell anti-viral signaling event that primed unin-
fected cells, the AUG 213 KO virus was compared to theWT virus at a
MOI of 3, to obtain a synchronized infection of cells, but the growth of
the AUG 213 KO virus was still significantly reduced (Figure 5B).
Furthermore, no apparent cytopathic effects were observed in RAW
264.7 cells infected with the AUG 213 KO or AUG S11213 KO
viruses. Taken together, these results suggest that, in the absence of
NSm/NSm9, infected cells produce an efficient anti-viral response that
leads to reduced virus production. To confirm that this phenotype was
dependent on the KO of both AUG 2 and 3, as in mice, the AUG 2 KO
and AUG 3 KO single mutants were compared to the WT and AUG
213 KO viruses in RAW 264.7 cells (Figure 5C). The virus production
from the AUG 2 KO or AUG 3 KO mutants was similar to that of the
WT virus, demonstrating that expression of NSm or NSm9 alone is
sufficient for the virus to efficiently replicate in murine macrophage-
like RAW 264.7 cells.
Impact of the M-encoded accessory proteins on virus production in
mosquito cells and infectivity in Aedes aegyti mosquitoes
Because RVFV is propagated in nature by a mosquito vector, we
tested the effect of the NSm-related proteins on virus production
in arthropod-derived Aedes albopictus cells (C6/36) (Figure 5D).
All mutant viruses that lacked one or both forms of the NSm
proteins were produced at reduced titers. The AUG S11213
KO virus was the most affected mutant virus, with a 3-log reduc-
tion in virus production compared to the WT virus. Mutants AUG
S1 KO and AUG 213 KO displayed an intermediate phenotype,
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Figure 5 Growth behavior of the selected AUGKO viruses in cell culture. (A) Virus production in fibroblasts. L929 cells were infected at anMOI of 0.01 (left panel) or 3
(right panel). Supernatants were harvested at different time points, and virus production was quantified using plaque assays. (B, C) Virus production in RAW 246.7
cells. Cells were infected at anMOI of 0.01 (B left panel, C) or 3 (B right panel), and virus production was quantified using plaque assays. (D) Virus production in C6/36
cells infected at an MOI of 0.01. Virus production was monitored for 96 h PI. All values correspond to the average of a biological triplicate, and the corresponding error
bars are reported. Growth curves are representative of several independent experiments.
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suggesting a cooperative interaction between P78 and NSm in
mosquito cells.
Next, we compared the ability of the different mutant viruses to
infect and disseminate successfully within a mosquito vector (Figure 6).
Aedes aegyptimosquitoes display high infection and dissemination rates
after artificial infection with WT RVFV.38 To this end, Aedes aegypti
mosquitoes were infected with purified WT or mutant viruses using an
artificial feeding system, and the infection by WT virus was compared
to those by the AUG S1 KO, AUG 213 KO, AUG S11213 KO and
AUG 415 KO viruses. To determine the infection and dissemination
rates, the infectious virus recovered from the body and head of infected
mosquitoes 14 and 21 days PI was quantified by plaque assays. Infection
and dissemination rates correspond to the ratio of virus-positive bodies
or heads, respectively, relative to the total number of mosquitoes tested.
We found that the infection rates for the AUG 213 KO and AUG 415
KO mutant viruses were similar to that of WT virus-infected mosqui-
toes at days 14 and 21 PI. The infection rate of the AUG S1 KO virus no
longer expressing P78 was only reduced at day 21 PI. In contrast, the
infection rate for the AUG S11213 KO virus was strongly altered, with
0% and 7% positive mosquitoes on days 14 and 21 PI, respectively,
compared to 33% and 57%, respectively, for the WT virus (Figure 6A).
These findings are consistent with recent observations of mosquitoes
infected with a mutant virus in which the entire NSm region has been
deleted.30
The dissemination rate of the AUG 213 KO virus was very similar
to that of theWT virus at day 14 PI, but it did not rise between days 14
and 21 PI, as it did for theWT virus. The KO of P78 markedly affected
the ability of the virus to disseminate within infected mosquitoes, as
measured by the detection of virus in the head of only one individual.
The infection rate of the AUG S11213 KO mutant virus was so low
that no conclusion could be drawn regarding its ability to disseminate
within a mosquito host (Figure 6B). The dissemination rate of the
AUG 415 KO virus was increased at day 14 PI and reduced at day
21 PI when compared with theWT virus, although not to the extent of
the other mutant viruses. Overall, the NSm-related proteins appeared
to modulate virus infectivity in C6/36 cell cultures by distinct and
possibly synergistic mechanisms. In mosquitoes, P78 is the major
determinant of virus dissemination, whileNSmalone only has aminor
contribution.
DISCUSSION
Five AUG codons are present in the NSm coding sequence of the
RVFV M segment. These AUG codons are alternatively used to
produce the two major structural glycoproteins GN and GC and
at least two accessory proteins NSm and P78, the latter consisting
of a fusion between the NSm and GN proteins. Mutant viruses
deleted of the entire NSm region and accordingly lacking express-
ion of NSm and P78 have been shown to be highly attenuated in
rats and to be defective for virus spread in mosquitoes.29–31 In this
study, we evaluated the relative contribution of the different NSm-
related proteins to RVFV infectivity and virulence in vertebrate and
invertebrate species. To this end, one or several of the AUG codons
in the NSm region were knocked out in the virulent ZH548 RVFV
strain, and mutant viruses were tested for their ability to propagate
in mice, a pertinent animal model to study RVFV pathogenesis, and
in mosquitoes, the natural vector of RVFV.36,38,39 In mice, we
found that NSm is a major virulence factor, as opposed to P78,
which does not seem to have any detectable effect on this model.
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Figure 6 Infection ofAedes aegyptimosquitoes byWT and AUGKOmutant viruses. (A,B) FemaleAedes aegytimosquitoes were infected withWT ormutant RVFV by
ingestion of blood meals containing preparations of infectious viruses (titer 6.63107 PFU/mL). Viral loads were analyzed in the bodies and heads of the infected
mosquitoes using plaque assays on different days PI. (A) Infection rates are given as the number of positive bodies divided by the total number of mosquitoes. (B) The
dissemination rate was calculated from the number of positive heads relative to the total number ofmosquitoes. The infection and dissemination rates were analyzed at
14 days PI (left panel) and 21 days PI (right panel).
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However, attenuation of RVFV can only be observed when AUG 2
and AUG 3 are concomitantly knocked out due to expression of a
13-kDa protein, NSm9, from AUG 3 that corresponds to a slightly
truncated, functionally active form of NSm. These findings were
unexpected because AUG 3 was not considered to contribute
significantly to the expression of viral proteins,19 presumably due
to its proximity to AUG 2. However, our results are consistent with
the reported anti-apoptotic function of NSm that can be mediated
in trans using plasmids expressing proteins from AUG 2, and to
some extent from AUG 3, of the M segment in cells infected by a
mutant RVFV deleted of the entire NSm region.26 The reason for
duplicate functionalities of the NSm protein in the virus is rather
unclear. The AUG 3 codon could be located in a more favorable
context for protein translation in a particular host or cell type, or
the methionine residue encoded by the AUG 3 codon could con-
tribute to a biological property of the NSm protein.
Interestingly, we found that production of mutant viruses lacking
NSm and NSm9 expression is strongly reduced in infected RAW
264.7 monocytic cells, whereas the growth of single AUG 2 KO or
AUG 3 KO mutant viruses remain comparable to that of the WT
virus (Figures 5B and 5C). The interplay between RVFV and
macrophages might tightly rely on the identity of the viral strain
and the nature of the infected macrophages, as the growth of a
mutant virus derived from an attenuated strain of RVFV (MP12)
that contains a deletion of the entire NSm region is not affected in
J774.1 macrophages.26 Macrophages have been shown to contribute
to RVFV invasion of the central nervous system, and viral antigens
can be detected in macrophages present in the liver, pancreas, ovar-
ies and splenic dendritic cells in vivo.37,39–43 Further studies are thus
needed to clarify the contribution of macrophages to RVFV patho-
genesis and to define the mechanisms by which NSm counteracts
host antiviral responses.
The NSm non-structural protein as well as its substitute NSm9 is
specifically transported to the surface of mitochondria (Figure 3).35
The anti-apoptotic activity of NSm requires its proper mitochon-
drial localization to be effective, and this activity lies within the 45
C-terminal amino acids of the protein.35 The association of NSm
with mitochondria may also be important in regulating the cellular
p38 MAPK response.44 p38 signaling can be triggered through
many different stimuli, such as exposure to UV, elevated reactive
oxygen species (ROS) or cytokines such as TNF-a or IL-1. In the
case of RVFV, p38 activation is triggered by increased levels of ROS,
which is regulated at least in part at the level of mitochondria.44,45
ROS production can be promoted in mitochondria by complex I as
part of the respiratory chain.45 Whether nicotinamide adenine
dinucleotide (NADH) dehydrogenase subunit 1, which is a com-
ponent of complex I and has been identified as a potential cellular
partner of the NSm protein,46 is involved in this process remains to
be addressed. Alternatively, NSm could modulate ROS production
by interacting with the cytosolic side of mitochondria, as shown for
other viral cytoplasmic proteins such as the core protein of hepatitis
C virus or the X protein of hepatitis B.47–49
A surprising finding is that P78 did not influence RVFV virulence in
our mouse model. We expected this protein to play a significant role
during virus infection in mice because a mutation that introduced a
novel AUG codon upstream of the authentic AUG 1 site and restored
P78 protein expression in a mammalian cell culture infected by the
AUG 1 KO mutant virus was selected (Supplementary Figures S1).
Althoughwe did not observe such a compensatorymutation emerging
in vivo, we introduced two additional stop codons downstream of
the AUG 1 KO (AUG S1 KO virus) to exclude any event that
would lead to P78 expression and enhance virus infectivity. The
secured AUG S1 KO mutant virus was not attenuated in mice
compared to the AUG 1 KO or WT viruses, confirming that P78
is not a determinant of RVFV virulence in a mammalian host
infected by the intraperitoneal route (Figure 4C). By contrast,
P78 appears as a major determinant of virus dissemination in
Aedes aegypti mosquitoes, suggesting that this protein is an essen-
tial component of the RVFV transmission cycle. Although NSm
does not significantly impact virus infectivity in the invertebrate
host, in contrast to what has been suggested previously,31 a coop-
erative interaction between the P78 and NSm proteins seems to
take place during infection of the mosquito vector. The triple KO
mutant virus is virtually incapable of replicating in mosquitoes
and grows to substantially lower levels in infected mosquito cells
compared to the AUG S1 KO or AUG 213 KO mutant viruses
(Figures 5D and 6).
P78 is a glycoprotein that localizes to the Golgi, where RVFV
particles have been shown to assemble prior to their release into
the extracellular medium.20,50 The two potential glycosylation
sites that are present in the GN and NSm sequences have been
shown to be modified in P78, an indication that both the NSm
and GN ectodomains are oriented towards the lumen of the endo-
plasmic reticulum.51 Such a topology favors a direct interaction
between P78 and the GC molecules processed from the same pre-
cursor and is consistent with the rapid detection of a P78/GC
heterodimer in pulse-chase experiments.21 P78 was initially found
to co-sediment with virus or virus-like particles.22–24 However, a
recent study shows that incorporation of large glycoprotein P78
into the virus particle is only observed in C6/36 mosquito cells,
suggesting a critical role for this protein in the invertebrate host.25
Interestingly, the sequence surrounding AUG 1 corresponds more
closely to the Kozak consensus sequence of Drosophila than of
vertebrates (Table 1)52 and could perhaps lead to higher express-
ion levels of P78 in arthropod cells infected by RVFV in compar-
ison to infected mammalian cells.
Despite the fact that P78 encompasses the entire amino-acid
sequence of NSm, we found that both proteins fulfill fundamentally
Table 1 The nucleotidic context of AUG codons present in the NSm region of the RVFV M segment (adapted from Cavener[52])
26 25 24 23 22 21 11 12 13 14
Kozak consensus sequence vertebrate G C C A/G C C A U G G
Kozak consensus sequence drosophila A U C A A A A U G A
AUG1 C A U U A A A U G U
AUG2 C C A G A G A U G A
AUG3 G A G G A G A U G C
AUG4 G A A A C C A U G G
AUG5 A U U G C A A U G A
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distinct functions to ensure virus propagation in both mosquito and
vertebrate hosts. Our results illustrate how arthropod-borne viruses
accommodate a wide host range whilemaintaining a compact genome
organization. To face a genomic size constraint, RNA viruses have
adopted various strategies to enrich their functional repertoire
without exceeding size limits, beyond which their probability of sur-
viving lethal mutations introduced by their error-prone RNA poly-
merase becomes limited. The use of multiple translation initiation
sites situated either in-frame, as for phleboviruses, or in overlapping
ORFs, as for orthobunyaviruses and hantaviruses, is one adaptive
solution.53 Gain-of-function mutations, even when they benefit virus
replication in only one host species, are maintained during evolution
by selective pressure exerted during constant invertebrate/vertebrate
transmission cycles.54,55
In conclusion, we show that the small cytosolic NSm protein of
RVFV is a major virulence factor in the mammalian host and that
NSm9 is a functionally active surrogate. A striking finding is that
NSm only has a limited effect in the mosquito vector, whereas P78,
a protein in which NSm remains fused to GN and that associates with
virus particles, critically influences RVFV dissemination in the inver-
tebrate host. The means by which these proteins facilitate virus spread
in different species and whether they cooperate in any way are ques-
tions that remain to be addressed.
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SUPPLEMENTARY INFORMATION 
Figure S1: Stability of the AUG 1 KO mutant virus in mammalian cell culture. (A) 
Vero E6 cells were infected with the AUG 1 KO mutant virus at an MOI of 0.01, cell 
culture supernatants recovered between 72 to 96 h PI were used to infect a new 
monolayer of Vero E6 cells, this infection cycle was repeated 5 times, and RNA was 
extracted from the cells at the end of each cycle. RNA was subjected to 3’-RACE 
followed by RT-PCR to amplify and sequence the 5’-end of the M segment. 
Sequences from the initial AUG 1 KO virus stock as well as from viruses harvested at 
passages 4 and 5 are reported in the antigenomic orientation on the respective 
chromatograms. Sites corresponding to the knocked out AUG 1 (black underlining) 
and to a stop codon present immediately upstream of the original AUG1 (red 
underlining) are highlighted. Nucleotide 10 (black box), consisting of a cytosine in 
the stock preparation but of a uracil in the viral RNA after 5 rounds of infections, is 
boxed in black. (B) Vero E6 cells were infected with wt ZH548 virus or preparations 
of AUG 1 KO viruses derived from the different passages. P78 was detected by 
western blotting with anti-NSm Abs in cell lysates recovered at 18 h PI. 
 
 

